Saga Lifesciences Limited | Saga Lifesciences Limited

This CDMO specializes in the development and manufacturing of oral solid dosage forms, including tablets, capsules, dry syrups (powder for reconstitution), and oral powders in sachets. The company also provides new product development, technology transfer, and third-party manufacturing services.

With a commercial presence in more than 50 countries and over 300 marketed product dossiers, the company supports pharmaceutical partners across regulated and emerging markets.

The manufacturing facility is approved by EU GMP, PIC/S, Health Canada, and multiple regulatory authorities in Rest of World (ROW) markets, demonstrating compliance with international quality standards.